⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

Official Title: SELF-CERV Pivotal Study: Method Comparison of Self-collection Using the Teal Wand Self-Collection Device and HCP (Health Care Provider) Cervical Collection for Detection of High-risk HPV (hrHPV) for Cervical Cancer Screening

Study ID: NCT06120205

Study Description

Brief Summary: The goal of this method comparison study is to compare the detection of hrHPV collected using the Teal Wand Self-Collection device to hrHPV detected from HCP (health care provider) cervical collection using primary HPV testing assays. Participants will be asked to use the Teal Wand to provide a self-collected sample prior to a healthcare provider collected sample to be tested for hrHPV. Secondary measure will include usability and preferences.

Detailed Description: To demonstrate that participants who are representative of the intended use population can understand the Instructions for Use (IFU) and appropriately use the Teal self-collection device to collect adequate vaginal cells/material for use in primary hrHPV screening (primary outcome). To produce sufficient primary hrHPV test results following self-collection, as compared to the current SoC method of HCP specimen collection, when paired samples are tested using FDA approved primary hrHPV assays (Roche cobas and/or BD OnClarity). Primary Effectiveness Objective • To evaluate the performance of a self-collect device for hrHPV detection as compared to standard of care (SoC) by: * Agreement of hrHPV self-collected sample(s) as compared to HCP-collected sample results. * Calculating the invalid rate of tested samples.

Eligibility

Minimum Age: 25 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: Yes

Locations

Birmingham OBGYN / Alabama Clinical Therapeutics, Birmingham, Alabama, United States

Planned Parenthood Arizona, Tucson, Arizona, United States

Planned Parenthood Northern California, San Francisco, California, United States

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Planned Parenthood Southern New England, New Haven, Connecticut, United States

Yale University, New Haven, Connecticut, United States

Woman's Hospital, Baton Rouge, Louisiana, United States

Johns Hopkins University, Baltimore, Maryland, United States

Planned Parenthood League of Massachusetts, Boston, Massachusetts, United States

Planned Parenthood St. Louis Region, Saint Louis, Missouri, United States

Washington University, Saint Louis, Missouri, United States

New York University Langone Hospital, Mineola, New York, United States

Unified Women's Clinical Research Raleigh, Raleigh, North Carolina, United States

Unified Women's Clinical Research - Lyndhurst, Winston-Salem, North Carolina, United States

Planned Parenthood Gulf Coast, Houston, Texas, United States

University of Wisconsin - Madison, Madison, Wisconsin, United States

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: